FENNEC PHARMACEUTICALS INC. — Director's Dealing 2010

Aug 20, 2010

SEC Form 4/A — Form 4/A

Issuer: ADHEREX TECHNOLOGIES INC (ADHXF)
CIK: 0001211583
Period of Report: 2010-08-17

Reporting Person: PORTER ARTHUR T (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-08-18	Stock Options (right to buy)	$0.045	A	0	Acquired	2017-08-18	Common Stock (4603668)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$3.25	2011-03-01	Common Stock (18621)	18621	Direct
Stock Options (right to buy)	$2.90	2011-05-21	Common Stock (4000)	4000	Direct
Stock Options (right to buy)	$1.95	2011-12-17	Common Stock (2000)	2000	Direct
Stock Options (right to buy)	$1.20	2011-05-18	Common Stock (18621)	18621	Direct
Stock Options (right to buy)	$1.20	2012-09-21	Common Stock (30000)	30000	Direct
Stock Options (right to buy)	$0.88	2012-12-14	Common Stock (2500)	2500	Direct
Stock Options (right to buy)	$0.28	2014-02-28	Common Stock (50000)	50000	Direct
Stock Options (right to buy)	$0.63	2014-04-30	Common Stock (170000)	170000	Direct
Stock Options (right to buy)	$0.28	2014-12-03	Common Stock (75000)	75000	Direct

Footnotes

F1: The options will vest 100% on the date reported above and were issued in AHX (TSX listed shares).

F2: in CDN